The Tox is an emerging wellness franchise offering lymphatic-based body sculpting services. With only 6 franchised units and 8 company-owned locations, this is a very early-stage system that began franchising in 2021. The total investment ranges from $258K-$449K, which is substantial for a service-based concept. Financial performance data shows strong average revenues of $1.1M across 5 company-owned units, but franchisees should note this data comes from company-owned operations that may not reflect franchisee performance. The franchise requires hands-on owner involvement and offers protected territories with 3-mile radius or 100,000 population minimum. Key concerns include the very limited operating history, high upfront costs, and 8% royalty rate with $1,000 minimum monthly payment.
Generated from 2025 Franchise Disclosure Document
AI-generated from FDD analysis — use as a checklist with your attorney
Total startup costs, working capital, and financial requirements
Training, marketing support, technology, and operational assistance
Royalty, marketing, technology, and other ongoing fees
Revenue data, P&L estimates, and financial projections
Lawsuits, disputes, and legal risk assessment
Territory rights, term length, non-compete, and transfer rules
82 legal provisions scored on a franchisee-friendliness scale
Unit growth trends, exit rates, and system trajectory
Similar to The Tox in category and investment range